Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells

Pharmacological Reports

Volumn 64, Issue 3, 2012, Pages 745-750

  Walczak, Katarzyna ^a,b   Turski, Waldemar A ^a,b   Rzeski, Wojciech ^a,c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Colon cancer; Kynurenic acid; p21 Waf1 Cip1; Proliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; KYNURENIC ACID; SMALL INTERFERING RNA;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CELL STRAIN HT29; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; IN VITRO STUDY; INCUBATION TIME; PROTEIN EXPRESSION;

EID: 84866079666     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70870-8     Document Type: Article

References (27)

1. Di Serio C, Cozzi A, Angeli I, Doria L, Micucci I, Pellerito S, Mirone P et al.: Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. Cell Mol Neurobiol, 2005, 25, 981-993.
2. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH: Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci, 2010, 115, 89-97.
3. Dolecka J, Urbanik-Sypniewska T, Skrzydło-Radomańska B, Parada-Turska J: Effect of kynurenic acid on the viability of probiotics in vitro. Pharmacol Rep, 2011, 63, 548-551.
4. Dotto GP: p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta, 2000, 1471, M43-56.
5. Glavin GB, Bose R, Pinsky C: Kynurenic acid protects against gastroduodenal ulceration in mice injected with extracts from poisonous Atlantic shellfish. Prog Neuropsychopharmacol Biol Psychiatry, 1989, 13, 569-572.
6. Glavin GB, Pinsky C: Kynurenic acid attenuates experimental ulcer formation and basal gastric acid secretion in rats. Res Commun Chem Pathol Pharmacol, 1989, 64, 111-119.
7. Glavin GB, Pinsky C, Bose R: Gastrointestinal effects of contaminated mussels and putative antidotes thereof. Canad Dis Wkly Rep, 1990, 16, 111-115.
8. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX: The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci, 2001, 21, 7463-7473.
9. Kaszaki J, Palasthy Z, Erczes D, Racz A, Torday C, Varga G, Vécsei L, Boros M: Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil, 2008, 20, 53-62.
10. Kuc D, Rahnama M, Tomaszewski T, Rzeski W, Wejksza K, Urbanik-Sypniewska T, Parada-Turska J et al.: Kynurenic acid in human saliva - does it influence oral microflora? Pharmacol Rep, 2006, 58, 393-398.
11. Kuc D, ZgrajkaW, Parada-Turska J, Urbanik-Sypniewska T, Turski WA: Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids, 2008, 35, 503-505.
12. Litchfield JT, Wilcoxon FA: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
13. Liu S, Bishop WR, Liu M: Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist, 2003, 6, 183-195.
14. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA, 1995, 92, 5451-5455.
15. Paluszkiewicz P, Zgrajka W, Saran T, Schabowski J, Piedra JL, Fedkiv O, Rengman S et al.: High concentration of kynurenic acid in bile and pancreatic juice. Amino Acids, 2009, 37, 637-641.
16. Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer-Szerszeń M, Turski W: Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int, 2006, 26, 422-426.
17. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW: Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol, 1996, 149, 381-387.
18. Ramondetta L, Mills GB, Burke TW, Wolf JK: Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res, 2000, 6, 278-284.
19. Rzeski W, Turski L, Ikonomidou C: Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA, 2001, 98, 6372-6377.
20. Schwarcz R, Pellicciari R: Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther, 2002, 303, 1-10.
21. Turski MP, Turska M, Zgrajka W, Bartnik M, Kocki T, TurskiWA: Distribution, synthesis, and absorption of kynurenic acid in plants. Planta Med, 2011, 77, 858-864.
22. Turski MP, Turska M, Zgrajka W, Kuc D, Turski WA: Presence of kynurenic acid in food and honeybee products. Amino Acids, 2009, 36, 75-80.
23. Varga G, Erces D, Fazekas B, Fülöp M, Kovács T, Kaszaki J, Fülöp F et al.: N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat. Neurogastroenterol Motil, 2010, 22, 217-225.
24. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L: Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem, 2006, 281, 22021-22028.
25. Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S et al.: Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem, 2002, 277, 36329-36337.
26. Yamamoto H, Soh JW, Shirin H, Xing WQ, Lim JT, Yao Y, Slosberg E et al.: Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene, 1999, 18, 103-115.
27. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, Yang K, Augenlicht LH: Targeted inactivation of the p21(WAF1/cip1) gene enhances Apcinitiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res, 2001, 61, 565-569.